Literature DB >> 28090253

The Incremental Effect of Obesity on Myocardial Fibrosis In Patients with Aortic Stenosis.

Se-Jung Yoon1.   

Abstract

Entities:  

Year:  2016        PMID: 28090253      PMCID: PMC5234344          DOI: 10.4250/jcu.2016.24.4.274

Source DB:  PubMed          Journal:  J Cardiovasc Ultrasound        ISSN: 1975-4612


× No keyword cloud information.
REFER TO THE PAGE 303-311 There are many studies that show the myocardial fibrosis resulting from hypertension, aortic stenosis or hypertrophic cardiomyopathy, which are under the same condition with chronic pressure overloading.1)2)3)4) Multiple factors are recommended for impaired cardiac function in patients with hypertension, such as inflammation, adaptive ventricular remodeling, increased mechanical stress inducing subsequent ventricular hypertrophy, interstitial and perivascular fibrosis, endothelial dysfunction and neurohormonal factors.5)6)7)8)9)10) The development of left ventricular (LV) hypertrophy is actually a combined consequence of chronic pressure or volume overload in hypertension or aortic stenosis. To compensate for chronic pressure overload in these subjects, LV wall thickness gradually increases in order to normalize wall stress, leading to concentric LV remodeling and hypertrophy.11)12)13) Activation of several biological processes including various hormones, growth factors and cytokines also contribute to protein genesis by promoting muscle cell growth, leading to structural alterations and remodeling.14) We can inference the fatigue and essential compensatory mechanism of myocardium. The similar process can occur in obese patients. Moderate to severe cases of obesity was presented as leading to increased LV wall stress, compensatory LV hypertrophy and LV dysfunction. Alpert15) used a term of ‘obesity cardiomyopathy’ expressing the series of myocardial dysfunction. Compared with healthy lean individuals, increased epicardial adipose tissue in obese group is expected to result in more extensive fatty infiltration in the myocardium.16) They showed the correlation between incidence of atrial fibrillation and an excess adiposity and fibrosis in obesity with histologic demonstration. 17) In this study, Ávila-Vanzzini et al.18) presented concomitant overweight and obesity (OW/O) leading to pathological LV remodeling in patients with aortic stenosis. The most interesting point is that the authors revealed histologic patterns correlated well with body mass index or global longitudinal strain (GLS). Although not all tissues were obtained due to safety implications for patients, they showed and definitized the myocardial change in the concrete. However, the assessment of the area of fibrosis or lipid vacuoles in 5 fields leaves an inaccurate possibility for objective calculation. The other attractive point of this study is incremental effect of obesity on this histologic change. The authors tried to maximize the setting of myocardial dysfunction both with obesity and chronic pressure-overloading condition (aortic stenosis). GLS imaging is being accepted for objective tool for systolic cardiac function.19)20) In general, they reasonably placed the proper characters with compatible assessment tool to show the correlation of imaging and histologic pattern.
  19 in total

Review 1.  Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy.

Authors:  G de Simone; F Pasanisi; F Contaldo
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

2.  Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy.

Authors:  Makoto Saito; Hideki Okayama; Toyofumi Yoshii; Haruhiko Higashi; Hiroe Morioka; Go Hiasa; Takumi Sumimoto; Shinji Inaba; Kazuhisa Nishimura; Katsuji Inoue; Akiyoshi Ogimoto; Yuji Shigematsu; Mareomi Hamada; Jitsuo Higaki
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-01-12       Impact factor: 6.875

Review 3.  Local and systemic effects of the multifaceted epicardial adipose tissue depot.

Authors:  Gianluca Iacobellis
Journal:  Nat Rev Endocrinol       Date:  2015-04-07       Impact factor: 43.330

Review 4.  Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.

Authors:  M A Alpert
Journal:  Am J Med Sci       Date:  2001-04       Impact factor: 2.378

5.  Left ventricular diastolic wall strain and myocardial fibrosis in treated hypertension.

Authors:  Yen-Wen Liu; Wen-Huang Lee; Chih-Chan Lin; Yao-Yi Huang; Wei-Ting Lee; Cheng-Han Lee; Liang-Miin Tsai; Jyh-Hong Chen; Wei-Chuan Tsai
Journal:  Int J Cardiol       Date:  2014-01-09       Impact factor: 4.164

6.  Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.

Authors:  B López; R Querejeta; N Varo; A González; M Larman; J L Martínez Ubago; J Díez
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

7.  Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Cristina Monteduro; Bianca Bonzi; Anna Paini; Sara Viola; Paolo Poisa; Damiano Rizzoni; Maurizio Castellano; Enrico Agabiti-Rosei
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

8.  Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.

Authors:  Nazha Hamdani; Kalkidan G Bishu; Marion von Frieling-Salewsky; Margaret M Redfield; Wolfgang A Linke
Journal:  Cardiovasc Res       Date:  2012-12-04       Impact factor: 10.787

Review 9.  Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart Diseases.

Authors:  Yau-Huei Lai; Chi-In Lo; Yih-Jer Wu; Chung-Lieh Hung; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

10.  Left Ventricular Strain and Myocardial Fibrosis in Congenital Aortic Stenosis.

Authors:  Susan M Dusenbery; Fatima I Lunze; Michael Jerosch-Herold; Tal Geva; Jane W Newburger; Steven D Colan; Andrew J Powell
Journal:  Am J Cardiol       Date:  2015-07-28       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.